Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel C Patin

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Plos One|April 7, 2017
Trehalose dimycolate interferes with FcγR-mediated phagosome maturation through Mincle, SHP-1 and FcγRIIB signallingEmmanuel C Patin, Anna C Geffken, Sam Willcocks, et al.
Mucosal Immunology|October 20, 2019
Interleukin-7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell responseMaya Hassane, Youenn Jouan, Florent Creusat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2016
IL-27 Induced by Select Candida spp. via TLR7/NOD2 Signaling and IFN-β Production Inhibits Fungal ClearanceEmmanuel C Patin, Adam V Jones, Aiysha Thompson, et al.
Journal for Immunotherapy of Cancer|August 8, 2020
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancerEva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2014
Biochemical and antiparasitic properties of inhibitors of the Plasmodium falciparum calcium-dependent protein kinase PfCDPK1Keith H Ansell, Hayley M Jones, David Whalley, et al.
Journal for Immunotherapy of Cancer|March 22, 2022
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockadeEmmanuel C Patin, Magnus T Dillon, Pablo Nenclares, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor MicroenvironmentMagnus T Dillon, Katharina F Bergerhoff, Malin Pedersen, et al.
Nature Communications|August 1, 2025
Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trialMagnus T Dillon, Emmanuel C Patin, Kabir Mohammed, et al.
Cancer Research Communications|October 22, 2025
Xevinapant plus chemoradiotherapy negatively sculpts the tumour immune microenvironment in head and neck cancerCharleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev, et al.
Journal for Immunotherapy of Cancer|March 26, 2022
CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanomaGalabina Bozhanova, Jehanne Hassan, Lizzie Appleton, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Plos One|April 7, 2017
Trehalose dimycolate interferes with FcγR-mediated phagosome maturation through Mincle, SHP-1 and FcγRIIB signallingEmmanuel C Patin, Anna C Geffken, Sam Willcocks, et al.
Mucosal Immunology|October 20, 2019
Interleukin-7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell responseMaya Hassane, Youenn Jouan, Florent Creusat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2016
IL-27 Induced by Select Candida spp. via TLR7/NOD2 Signaling and IFN-β Production Inhibits Fungal ClearanceEmmanuel C Patin, Adam V Jones, Aiysha Thompson, et al.
Journal for Immunotherapy of Cancer|August 8, 2020
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancerEva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2014
Biochemical and antiparasitic properties of inhibitors of the Plasmodium falciparum calcium-dependent protein kinase PfCDPK1Keith H Ansell, Hayley M Jones, David Whalley, et al.
Journal for Immunotherapy of Cancer|March 22, 2022
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockadeEmmanuel C Patin, Magnus T Dillon, Pablo Nenclares, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor MicroenvironmentMagnus T Dillon, Katharina F Bergerhoff, Malin Pedersen, et al.
Nature Communications|August 1, 2025
Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trialMagnus T Dillon, Emmanuel C Patin, Kabir Mohammed, et al.
Cancer Research Communications|October 22, 2025
Xevinapant plus chemoradiotherapy negatively sculpts the tumour immune microenvironment in head and neck cancerCharleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev, et al.
Journal for Immunotherapy of Cancer|March 26, 2022
CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanomaGalabina Bozhanova, Jehanne Hassan, Lizzie Appleton, et al.
Pageof 3